MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 85 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,115,104 | -44.5% | 511,193 | -25.1% | 0.01% | -50.0% |
| Q2 2023 | $7,411,852 | +57.4% | 682,491 | 0.0% | 0.03% | +52.9% |
| Q1 2023 | $4,709,188 | +262836.2% | 682,491 | +51.7% | 0.02% | +183.3% |
| Q4 2022 | $1,791 | -99.9% | 449,948 | -14.8% | 0.01% | -53.8% |
| Q3 2022 | $3,511,000 | +577.8% | 527,925 | +392.8% | 0.01% | +550.0% |
| Q2 2022 | $518,000 | -48.4% | 107,123 | +26.9% | 0.00% | -33.3% |
| Q4 2021 | $1,003,000 | -4.3% | 84,402 | -8.4% | 0.00% | 0.0% |
| Q3 2021 | $1,048,000 | -36.6% | 92,101 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $1,652,000 | +15.8% | 92,101 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,426,000 | +26.9% | 92,101 | 0.0% | 0.01% | +20.0% |
| Q4 2020 | $1,124,000 | -5.0% | 92,101 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $1,183,000 | – | 92,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |